Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...
A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...
A bill that would ban the use of mRNA vaccines, including for Covid-19, is on its way to the House floor after passing out of ...
In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of ...
As global capital reassesses the investment value of innovative Chinese companies, the development of innovative vaccines in ...
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials ...
There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...
The Phase I data aligns with previous preclinical findings, showing over 95% protection in non-human primates, comparable to ...